Company logos shown on QuarterCharts are trademarks of their respective owners and are used solely for identification of the company whose data is displayed. Their use does not imply endorsement, sponsorship, or affiliation with the trademark owners. Full trademarks policy.
Quarters are matched automatically on the comparison year — pick once, both periods stay aligned.
This period ended in a net loss: costs exceeded what revenue funded, so the red Loss band appears as a second source alongside Revenue. Every figure is as filed.
| Line item | FY2026 (Q2) | FY2025 (Q2) |
|---|---|---|
| Revenue | $72.11M | $78.19M |
| COGS | $22.78M | $29.08M |
| Gross Profit | $49.34M | $49.11M |
| R&D | $1.41M | $1.25M |
| SG&A | — | $0 |
| D&A | $529K | $711K |
| Other OpEx | $43.83M |
QuarterCharts · SEC EDGAR data · SKIN · Comparing FY2026 (Q2) vs FY2025 (Q2)
| $0 |
| Operating Income | $3.57M | $47.15M |
| Interest Exp. | $5.03M | $4.14M |
| Other Non-Op | — | $24.29M |
| Pretax Income | — | $18.72M |
| Tax | $1.21M | $993K |
| Net Income | — | $17.73M |
